
PMC:7376845 / 28020-28223
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"712","span":{"begin":180,"end":184},"obj":"Gene"},{"id":"718","span":{"begin":67,"end":74},"obj":"Species"},{"id":"719","span":{"begin":108,"end":118},"obj":"Species"},{"id":"725","span":{"begin":15,"end":21},"obj":"Chemical"}],"attributes":[{"id":"A712","pred":"tao:has_database_id","subj":"712","obj":"Gene:59272"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"Tax:9606"},{"id":"A719","pred":"tao:has_database_id","subj":"719","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T270","span":{"begin":49,"end":53},"obj":"Disease"},{"id":"T271","span":{"begin":108,"end":116},"obj":"Disease"},{"id":"T272","span":{"begin":108,"end":112},"obj":"Disease"}],"attributes":[{"id":"A270","pred":"mondo_id","subj":"T270","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A271","pred":"mondo_id","subj":"T271","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A272","pred":"mondo_id","subj":"T272","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T299","span":{"begin":47,"end":48},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T300","span":{"begin":76,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T243","span":{"begin":141,"end":148},"obj":"Chemical"}],"attributes":[{"id":"A243","pred":"chebi_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/CHEBI_53000"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T220","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
2_test
{"project":"2_test","denotations":[{"id":"32700671-16796401-29327487","span":{"begin":76,"end":78},"obj":"16796401"},{"id":"32700671-32065055-29327488","span":{"begin":199,"end":201},"obj":"32065055"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}
MyTest
{"project":"MyTest","denotations":[{"id":"32700671-16796401-29327487","span":{"begin":76,"end":78},"obj":"16796401"},{"id":"32700671-32065055-29327488","span":{"begin":199,"end":201},"obj":"32065055"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Interestingly, CR3022, which was isolated from a SARS convalescent patient [22], showed cross-reactivity to SARS-CoV-2 RBD and recognises an epitope that does not overlap with the ACE2 binding site [28]."}